By Dr. John L. Ferrell III, M.D.(*)
⚡ Quick Answer
PRP (platelet-rich plasma) is not covered by most commercial insurance plans, Medicare, or Medicaid in 2026. Insurers classify it as “investigational,” which means patients pay out of pocket. Tricare offered provisional coverage for PRP in specific conditions (mild to moderate knee osteoarthritis and tennis elbow) from 2019 through September 2024, but that provisional coverage has since ended, so Tricare beneficiaries should confirm current status directly before assuming coverage. For everyone else, published industry pricing for PRP typically runs from about $500 to $2,500 per injection depending on the body part and provider. HSA and FSA funds can generally be used. Your initial consultation at ROSM is often covered by insurance even when the treatment is not.
You did the research. You found a treatment with real clinical evidence behind it. You made an appointment. And then you got the call from the billing department and heard a number that made you pause.
This is the part of the PRP conversation that most providers do not handle well. The answer to “is PRP covered by insurance” is almost always no, and patients deserve to understand why, not just receive the bill.
The reason has less to do with the evidence for PRP and more to do with how the insurance approval process works. Understanding that distinction changes how you think about the cost.
Why Insurance Won’t Cover PRP: The Real Explanation
Most major insurers, including Blue Cross Blue Shield, Aetna, Cigna, and United Healthcare, classify PRP as an “investigational” or “experimental” treatment for musculoskeletal conditions. That classification is the reason for the denial.
Here is what “investigational” actually means in insurance terms: it does not mean the treatment is unproven. It means the treatment has not gone through the specific regulatory and approval pathway that insurers recognize as sufficient to mandate coverage. For a treatment to move from “investigational” to “covered,” it typically needs either FDA approval as a drug or device, or a major guideline change from an organization like CMS (Centers for Medicare and Medicaid Services).
PRP runs into a specific structural problem, one we’ve written about in more depth before: because it is made from your own blood and is not a patented pharmaceutical product, there is no pharmaceutical company with a financial incentive to fund the large-scale Phase III clinical trials required for FDA drug approval. Those trials cost tens to hundreds of millions of dollars. No company can patent your blood cells, so no company will pay that cost.
The result is a treatment that has significant and growing clinical support in the medical literature, but has not cleared the specific administrative hurdles that insurers use as their coverage threshold. The evidence exists. The pathway to coverage does not.
This is not a fringe observation. Johns Hopkins Medicine, Cedars-Sinai, and other major academic medical centers all offer PRP while openly noting it is not covered by insurance. The same institutions publish or cite the research supporting it. The disconnect is structural, not scientific.
The One Real (and Recently Changed) Exception: Who Covers PRP?
Tricare, the health coverage program for active-duty U.S. military members and certain veterans, offered provisional coverage for PRP in specific musculoskeletal conditions, mild to moderate chronic knee osteoarthritis and lateral epicondylitis (tennis elbow), from October 2019 through September 2024. That provisional window has closed. If you are a Tricare beneficiary, do not assume coverage is still active. Confirm current status directly with Tricare or ask ROSM’s billing team to verify before your appointment.
Medicare sometimes covers PRP when it is administered as part of an officially approved clinical trial, primarily for conditions like chronic non-healing diabetic foot wounds. For standard musculoskeletal PRP for a knee, shoulder, or elbow, Medicare does not provide coverage.
Some patients have had limited success submitting claims to out-of-network benefit riders on their private insurance plans, particularly when accompanied by a detailed letter of medical necessity from their physician. This is not a reliable pathway, but it is worth exploring with your insurer before your first appointment.
For the majority of patients in the DC, Maryland, and Virginia area, PRP is a direct out-of-pocket expense.
How Much Does PRP Cost Without Insurance?
The cost of a PRP injection varies by provider, body part, and whether the treatment is ultrasound-guided. Published industry pricing for a single PRP injection typically runs from about $500 to $2,500 or more per session, depending on the joint treated and the provider. Ultrasound-guided injections, which ROSM uses to ensure precise placement, are typically at the higher end of that range because the imaging adds both accuracy and cost. For a full breakdown of what affects PRP pricing and recovery, see our PRP costs and recovery guide.
Most conditions respond well to one to two injections. Some chronic tendon problems or more significant joint damage may require two injections spaced four to six weeks apart. The total cost of a full PRP course is therefore typically between one and three injections, depending on the diagnosis.
For context: a single outpatient orthopedic surgery in the United States costs an average of $14,000 to $30,000 before anesthesia, facility fees, and post-operative physical therapy. Even without insurance coverage, PRP is often a fraction of the surgical alternative.
How to Pay for PRP: HSA, FSA, Superbills, and Financing
The most practical payment option for most patients is a Health Savings Account (HSA) or Flexible Spending Account (FSA). Because PRP is a medical procedure administered by a licensed physician for a diagnosed condition, it generally qualifies as an eligible medical expense under IRS guidelines. This means you pay with pre-tax dollars, effectively reducing the out-of-pocket cost by your marginal tax rate.
If you have an HSA, funds roll over year to year and can be accumulated specifically for planned procedures like PRP. If you have an FSA, coordinate with your employer about your plan year to make sure funds are available when you need them.
A superbill is another option worth discussing with ROSM’s billing team. A superbill is an itemized receipt with the procedure codes, diagnosis codes, and provider information that some insurance plans accept for out-of-network reimbursement requests. Insurers are not obligated to reimburse, and many will not for a treatment classified as investigational, but some patients with strong out-of-network benefits have received partial reimbursement this way.
Some practices also offer financing through medical credit programs. Ask ROSM’s team about financing options at your first visit.
Is PRP Worth the Out-of-Pocket Cost?
This is the question patients are really asking when they ask about insurance. The cost question and the value question are not the same, but they feel like the same question when you are holding an estimate.
PRP is not appropriate for every diagnosis or every patient. But for the conditions where the clinical evidence is strongest, including knee osteoarthritis, lateral epicondylitis (tennis elbow), rotator cuff tendinopathy, and plantar fasciitis, the comparison point is not “PRP versus free.” It is “PRP versus the next thing on the conventional pathway,” which is typically either continued cortisone injections or surgery.
Repeated cortisone injections are often covered by insurance, but research has shown they can accelerate cartilage loss over time and provide diminishing returns with each injection. Surgery for a torn rotator cuff or knee osteoarthritis involves general anesthesia, a surgical recovery measured in months, physical therapy, and risks that cortisone and PRP do not carry.
The cost calculation for a patient considering PRP is not simply the price of one or two injections. It is the cost of that treatment weighed against the cost, risk, and recovery time of the alternatives. Many patients who go through that comparison find that PRP, even without insurance coverage, is the more economical path.
At ROSM, the first step is a diagnostic evaluation with musculoskeletal ultrasound imaging. That appointment gives you a clear picture of the structural problem before any treatment is recommended. You will know what you are treating and why before you make any decisions about cost.
Frequently Asked Questions
Q: Does Blue Cross Blue Shield cover PRP injections?
A: No. Blue Cross Blue Shield, across most of its regional plans, classifies PRP as investigational for musculoskeletal conditions and does not provide coverage. Individual plan policies vary, so it is worth calling the member services number on the back of your card to confirm your specific plan’s position, but the standard answer is no.
Q: Is PRP covered by Medicare?
A: Standard Medicare does not cover PRP for musculoskeletal conditions like knee osteoarthritis, rotator cuff injuries, or tendinopathy. Medicare has covered PRP in limited clinical trial contexts for conditions like chronic diabetic wounds. For the conditions ROSM treats, patients on Medicare should expect to pay out of pocket.
Q: Can I use my HSA or FSA to pay for PRP?
A: In most cases, yes. PRP injections administered by a licensed physician for a diagnosed medical condition generally qualify as eligible medical expenses under IRS guidelines. Confirm with your HSA or FSA administrator before your appointment, as eligibility can depend on how the procedure is coded.
Q: How much does PRP cost in the DC, Maryland, and Virginia area?
A: Published industry pricing for PRP typically runs from $500 to $2,500 or more per injection depending on the joint and provider. We discuss all costs transparently at your first visit, and our team can answer questions about HSA/FSA eligibility and superbill options.
Q: Is my initial consultation at ROSM covered by insurance?
A: In most cases, yes. An evaluation visit with a physician to assess a musculoskeletal complaint is a billable medical service that most insurance plans cover. The treatment itself may not be covered, but the diagnostic process typically is. This is worth doing regardless of your ultimate treatment decision, because the ultrasound imaging we use gives you an accurate picture of what is actually happening in the joint.
Conclusion
PRP is not covered by insurance in 2026 for the vast majority of patients, and the reason why says more about the insurance approval system than it does about the treatment. The evidence for PRP in the right indications is solid and growing. The pathway that would force insurers to cover it does not exist yet, and may not for years.
That does not mean PRP is out of reach. HSA and FSA funds, superbills, and transparent pricing at your first visit make the cost manageable for many patients. And for patients considering surgery or continued cortisone as the alternative, the comparison often shifts significantly when all the costs are on the table.
If you have questions about whether PRP is appropriate for your situation and what it would cost at ROSM, the right starting point is an evaluation. Your consultation is covered by most insurance plans.
